Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05179512 · ClinicalTrials.gov registry record
Replication of the INSPIRE Trial in Healthcare Claims Data
A clinical trial of Chronic Obstructive Pulmonary Disease, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 98,278
- Enrollment target
- 1
- Study location
NCT05179512 is a study of Chronic Obstructive Pulmonary Disease that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 98,278 participants, above the 611-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (15985% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05179512, a study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 98,278 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Conditions Studied
Interventions
- DRUG Tiotropium
- DRUG salmeterol-fluticasone
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98,278 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2021-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05179512
The ClinicalTrials.gov registry entry for NCT05179512 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 98,278 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 611-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (15985% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 2 interventions - of which Tiotropium is the first listed.
NCT05179512 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05179512 about?
NCT05179512 is a clinical study titled "Replication of the INSPIRE Trial in Healthcare Claims Data". Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such...
What is the current status of trial NCT05179512?
This trial is currently completed. The enrollment target is 98,278 participants. The study started on 2020-09-22. Estimated completion is 2021-08-30.
What conditions does trial NCT05179512 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.
What interventions are being tested in trial NCT05179512?
The interventions under investigation include: Tiotropium (DRUG), salmeterol-fluticasone (DRUG).
Who is sponsoring clinical trial NCT05179512?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05179512 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
RECRUITING
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
COPD Care Pathway Among Patients With Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.